GBLP — Global Pharmatech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Global Pharmatech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2003 March 31st	2004 March 31st	2005 December 31st	2006 December 31st	2007 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.607	-0.034	0.201	-1.23	-3.3
Depreciation
Amortisation
Non-Cash Items	0.318	0.107	-0.073	0.56	2.17
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.01	-0.134	-2.52	0.398	0.334
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-0.279	-0.061	-1.86	0.263	-0.383
Capital Expenditures	0	0	-0.381	-0.415	-0.192
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.026	0	—	0.025	-0.007
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	0.026	0	-0.381	-0.39	-0.199
Financing Cash Flow Items	-0.211	0.051	0.248	—	0.176
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.086	0.061	2.73	4.83	0.176
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.169	0	0.498	4.86	-0.136